Overview

A Study for HSK44459 in Participants With Atopic Dermatitis

Status:
RECRUITING
Trial end date:
2026-03-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of HSK44459 in adults with Atopic Dermatitis
Phase:
PHASE2
Details
Lead Sponsor:
Xizang Haisco Pharmaceutical Co., Ltd